← Browse by Condition
Medical Condition

adrenocortical tumor

Total Trials
2
Recruiting Now
2
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for adrenocortical tumor sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — adrenocortical tumor Clinical Trials

How many clinical trials are currently recruiting for adrenocortical tumor?
ClinicalMetric currently tracks 2 actively recruiting clinical trials for adrenocortical tumor, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 2. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for adrenocortical tumor?
adrenocortical tumor research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a adrenocortical tumor clinical trial?
Eligibility criteria for adrenocortical tumor trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Azienda Ospedaliera di Padova 1 trial
University Hospital Olomouc 1 trial

Recruiting Clinical Trials

NCT07072143
Recruiting
An International Study on Pediatric Patients With Rare Tumors.
Enrollment
6,250 pts
Location
Italy
Sponsor
Azienda Ospedaliera di Padova
View Trial →
NCT06050057
Recruiting
Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy
Enrollment
100 pts
Location
Czechia
Sponsor
University Hospital Olomouc
View Trial →

Related Conditions

paraganglioma phaeochromocytoma (1) melanoma and other malignant neoplasms of skin (1) gastrointestinal stromal tumor gist (1) pancreatic tumors (1) esthesioneuroblastoma olfactory (1) mesothelioma (1) nasopharyngeal carcinoma npc (1) nut carcinoma (1) pleuropulmonary blastoma (1) salivary gland tumors (1) thymic tumors (1) thyroid carcinoma (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology